Marker vaccines and the impact of their use on diagnosis and prophylactic measures.

Vannie, P; Capua, I; Le Potier, M F; Mackay, D K J; Muylkens, B; Parida, S; Paton, D J; Thiry, E

Vannie, P; Capua, I; Le Potier, M F; Mackay, D K J; Muylkens, B; Parida, S; Paton, D J; Thiry, E.

Affiliation

Vannie P; Agence française de sécurité sanitaire des aliments (AFSSA), BP 53, 22440 Ploufragan, France.

Rev Sci Tech ; 26(2): 351-72, 2007 Aug.

Article in En | MEDLINE | ID: mdl-17892157

Subject(s)

Animal Diseases/diagnosis; Animal Diseases/prevention & control; Vaccination/veterinary; Vaccines, Marker; Animals; Diagnosis, Differential; Vaccination/methods; Viral Vaccines/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vaccination / Vaccines, Marker / Animal Diseases Type of study: Diagnostic_studies / Screening_studies Limits: Animals Language: En Journal: Rev Sci Tech Journal subject: DOENCAS TRANSMISSIVEIS / MEDICINA VETERINARIA Year: 2007 Document type: Article Affiliation country: France Country of publication: France

Search on Google

Add to My VHL

XML

PubMed Links